Log In
Print
BCIQ
Print
Print this Print this
 

2330672 (GSK2330672)

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionOral small molecule inhibitor of solute carrier family 10 sodium-dependent bile acid transporter member 2 (SLC10A2; ASBT; IBAT)
Molecular Target Solute carrier family 10 sodium-dependent bile acid transporter member 2 (SLC10A2) (ASBT) (IBAT)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today